Francois Cedric — SEC Form 4 filings
SEC reporting owner CIK 1658080. 21 Form 4 filings on record with FilingPulse; latest filed 2026-05-14.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2024-01-17 to 2026-05-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 21 legs across 15 filings — 736,366 shares, $29,276,308 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 46.
- Largest priced transaction: sale of 116,512 shares @ $64.92 ($7,563,528) in Apellis Pharmaceuticals, Inc., filed 2024-03-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) | Chief Executive Officer, Director | 21 | — | 21 legs · 736,366 sh · $29,276,308 | 46 |
Form 4 filings — Francois Cedric
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-14 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Code (U): 425,968 · Code (U): 372,815 · Code (U): 472,065 · Code (U): 300,000 · Code (U): 234,411 · Grant/award (A): 143,750 · +20 more | EDGAR |
| 2026-03-13 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Gift (G): 64,869 @ $0 · Gift (G): 64,869 @ $0 | EDGAR |
| 2026-02-05 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Option exercise (M): 8,840 @ $3.76 · Option exercise (M): 8,840 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/award (A): 195,952 @ $0 | EDGAR |
| 2026-01-23 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 27,192 @ $21.77 | EDGAR |
| 2026-01-21 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 8,182 @ $19.79 | EDGAR |
| 2026-01-15 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 10,186 @ $22.19 | EDGAR |
| 2025-08-29 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 175,037 @ $28.19 · Sale (S): 49,963 @ $28.39 | EDGAR |
| 2025-07-18 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Option exercise (M): 8,997 @ $4.31 · Sale (S): 19,725 @ $20.21 · Option exercise (M): 8,997 (derivative) @ $0 | EDGAR |
| 2025-07-16 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Option exercise (M): 65,203 @ $4.31 · Sale (S): 137,465 @ $20.19 · Option exercise (M): 800 @ $4.31 · Sale (S): 1,900 @ $20.09 · Option exercise (M): 65,203 (derivative) @ $0 · Option exercise (M): 800 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/award (A): 287,500 (derivative) @ $19.39 | EDGAR |
| 2025-01-30 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 2,824 @ $29.52 | EDGAR |
| 2025-01-23 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 13,551 @ $30.43 | EDGAR |
| 2025-01-21 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 6,007 @ $29.96 · Grant/award (A): 130,662 @ $0 | EDGAR |
| 2025-01-14 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 6,247 @ $28.70 | EDGAR |
| 2024-11-01 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Other (J): 182,146 @ $0 | EDGAR |
| 2024-03-05 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Option exercise (M): 50,000 @ $3.76 · Option exercise (M): 200,000 @ $4.31 · Sale (S): 28,868 @ $62.21 · Sale (S): 41,704 @ $62.96 · Sale (S): 62,503 @ $64.26 · Sale (S): 116,512 @ $64.92 · +3 more | EDGAR |
| 2024-02-13 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 3,962 @ $67.77 | EDGAR |
| 2024-01-31 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 2,843 @ $64.14 | EDGAR |
| 2024-01-23 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Sale (S): 13,431 @ $65.00 | EDGAR |
| 2024-01-17 | 4 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/award (A): 72,094 @ $0 · Sale (S): 7,851 @ $66.81 · Grant/award (A): 104,834 (derivative) @ $66.30 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1658080 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →